When my father was diagnosed with last stage lung cancer, we juiced fresh green papaya and apples, since the strong papaya enzyme was believed to remove the coating of cancer cells so that the body’s immune system can attack them. The doctor said he would live for another 3 months, he lived for 9 more months at home.

Today I read an article at nytimes.com with similar cancer shield properties in the form of medicinal drug (immunotherapeutic meds) . See the story below:

The first indication that a cancer’s protective shield might be breached came in 2010, after a trial of the drug ipilimumab in patients with otherwise untreatable melanoma. The drug unleashes the immune system, letting it overwhelm tumors even if they have a protective shield.

Patients who took the drug survived an average of 10 months, or 4 months longer than those randomly assigned to a different treatment. And about 20 percent of patients who responded have now survived up to 10 years. It was the first drug to improve survival for patients with metastatic melanoma in a randomized trial.

“It was spectacular,” said Dr.Axel Hoos, vice president for oncology research and development at GlaxoSmithKline, who helped develop the drug when he was at Bristol-Myers Squibb. “Until that tipping point, immunotherapy had a bad name. It didn’t work.”

The drug was approved for melanoma in March 2011, with a high price tag — $120,000 for a course of therapy.